Work

Target trial emulation of early docetaxel and enzalutamide for metastatic hormone‐sensitive prostate cancer

Year: 2025

Type: article

Source: British Journal of Urology

DOI: 10.1111/bju.70065

Authors: Yu Yang Soon, Ian C. Marschner, I. Manjula Schou, Christopher J Sweeney, Ian D. Davis, Martin R. Stockler, Andrew J. Martin

Institutions: The University of Sydney, National University of Singapore, National University Cancer Institute, Singapore, National Health and Medical Research Council, Australian and New Zealand Urogenital and Prostate Cancer Trials Group, The University of Adelaide, Eastern Health, Monash University, Concord Repatriation General Hospital, Chris O’Brien Lifehouse, The University of Queensland

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: Cancer Detection & Diagnosis Research-2022-Comprehensive genomic profiling of aggressive hormone sensitive prostate cancer

OpenAlex ID: W4415912407

FWCI: 0.591

Cites: 21

Cited by: 1

Related to: